Department of Surgery

Research News

Award Winners, 2018 Richard L. Simmons Lecture in Surgical Science/Department of Surgery Research Day


On May 2nd, 2018 we held our 16th Annual Research Day and Richard L. Simmons Lecture in Surgical Science. Attendees were treated to an outstanding presentation, “Considerations on the Creative Process in Clinical Problem Solving” by this years’ Richard L. Simmons lecturer, Elliot L. Chaikof, MD, PhD, Surgeon-in-Chief of the Beth Israel Deaconess Medical Center. 

Participants delivered 10 exceptional oral presentations and 47 outstanding poster presentations. The following presenters were selected for special recognition:

Oral Presentation Award Winners

Surgery Faculty Achievements Celebrated at 2018 Honors Convocation

The University of Pittsburgh paid tribute to the outstanding achievements of its faculty and students during their 42nd annual Honors Convocation on Friday, February 23, 2018 at the Carnegie Museums of Pittsburgh Music Hall in Oakland.

Pittsburgh Post-Gazette Spotlights NIH Stent Research by Dr. Bryan Tillman

Dr. Matthew Neal Receives Jacobson Promising Investigator Award


Congratulations to Matthew D. Neal, MD, who is the 2017 recipient of the American College of Surgeons (ACS) Jacobson Promising Investigator Award.

The $30,000 Joan L. and Julius H. Jacobson II Promising Investigator Award was established to recognize outstanding surgeons engaging in research, advancing the art and science of surgery, and demonstrating early promise of significant contribution to the practice of surgery and the safety of surgical patients.

Award Winners from the 15th Annual Richard L. Simmons Lecture in Surgical Science and Department of Surgery Research Day


Congratulations to our award recipients from the 15th Annual Richard L. Simmons Lecture in Surgical Science and Department of Surgery Research Day on May 10, 2017:

Oral Presentation Award Winners

  • First Place: Jennifer L. Miller-Ocuin, MD, “Inhibition of Autophagy Improves Pathologic and Biomarker Response to Pre-Operative Gemcitabine/Nab-Paclitaxel in Potentially Resectable Pancreatic Cancer: A Phase II Randomized Controlled Trial”